Patent AT-E400297-T1: [Translated] CTGF AS A TARGET MOLECULE IN THE TREATMENT OF MICROALBUMINURIA IN PATIENTS WITH DIABETIC NEPHROPATHY
Description
The present invention relates to methods and compounds for treating specific early stage aspects and late stage aspects of diabetic nephropathy. Methods and compounds for treating various physiological features associated with early stage and with late stage diabetic nephropathy are also provided.
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the complete Patent AT-E400297-T1: [Translated] CTGF AS A TARGET MOLECULE IN THE TREATMENT OF MICROALBUMINURIA IN PATIENTS WITH DIABETIC NEPHROPATHY on the official website. |
https://pubchem.ncbi.nlm.nih.gov/patent/AT-E400297-T1 |
Tags
- patent
- chemistry
- research
- innovation
- pubchem